The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic Leukemia. Hematol Oncol Stem Cell Ther 2022 Dec 23;15(4):219-222
Date
08/06/2021Pubmed ID
34352199DOI
10.1016/j.hemonc.2021.07.003Scopus ID
2-s2.0-85113165569 (requires institutional sign-in at Scopus site) 1 CitationAuthor List
Halahleh K, Al Rimawi D, Abu Ghosh A, Muradi I, Da'na W, Hamadani MAuthor
Mehdi H. Hamadani MD Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AllograftsHematopoietic Stem Cell Transplantation
Humans
Philadelphia Chromosome
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Protein Kinase Inhibitors